跳至主要内容
临床试验/NL-OMON22870
NL-OMON22870招募中不适用

Oral Fosfomycin versus Ciprofloxacin for Febrile Urinary Tract Infection in Men: a pilot study

one0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
one
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Competent male patient aged 18 years or above
  • 2. One or more symptom(s) suggestive of urinary tract infection (dysuria, frequency or
  • urgency; perineal or suprapubic pain; costo-vertebral tenderness or flank pain)
  • 3. Fever (ear or rectal temp of 38.2 oC or higher, or axillary temp of 38 oC or higher), or
  • history of feeling feverish with shivering or rigors in the past 24 hours
  • 4. Positive urine nitrate test and/or leucocyturia as depicted by positive leukocyte
  • esterase test or microscopy
  • 5. Hospital admission for presumed FUTI and empirical intravenous antibiotic treatment
  • with beta-lactams
  • 6. Positive urine (> 103 CFU/ml) culture and/or blood culture with E. coli susceptible to
  • fosfomycin, ciprofloxacin and the empirical intravenous beta-lactam treatment
  • 7. Fullfilment of criteria for safe iv to oral switch (hemodynamic stability, ability to
  • consume oral antibiotics, no gastrointestinal problems which affect absorption)

排除标准

  • 1. Known allergy to fosfomycin or ciprofloxacin
  • 2. Patients with known polycystic kidney disease
  • 3. Patients on permanent renal replacement therapy (hemodialysis or peritoneal
  • 4. Patients with history of kidney transplantation
  • 5. Patients with a permanent urinary catheter
  • 6. Patients with chronic renal failure (eGFR < 30 ml/min/1.73m3)
  • 7. Patients with renal abcess or pyonephrosis
  • 8. Patients with chronic bacterial prostatitis (defined as recurrent UTI with the same
  • uropathogen and no other clarifying underlying urological disorder)
  • 9. Patients with any diagnosed metastatic E. coli foci
  • 10. Patients with a double-J or nephrostomy catheter
  • 11. Concomitant systemic antibiotic treatment for another reason than FUTI
  • 12. Residence outside the Netherlands
  • 13. Inability to speak or read Dutch
  • Specific exclusion criteria for the FOS-MEN-pharm substudy is
  • 1. Incontinency for urine, which results in the inability to properly get urine samples.

研究者

发起方
one

相似试验